## Background: Trka, the high affinity, tyrosine kinase receptor for nerve growth factor (ngf) has been implicated as an oncogene in several neoplasms. in prostate cancer, inhibitors of the ngf/trka signal pathway results in tumor growth inhibition. in contrast, inhibition of this trk pathway in th
Mutational analysis of NCOA2 gene in prostate cancer and other common cancers
β Scribed by CHANG HYEOK AN; SANG WOOK PARK; NAM JIN YOO; SUG HYUNG LEE
- Book ID
- 109344173
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 81 KB
- Volume
- 119
- Category
- Article
- ISSN
- 0365-5555
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Missense somatic mutations in __IDH1__ gene affecting codon 132 have recently been reported in glioblastoma multiforme (GBM) and other gliomas. The recurrent nature of the __IDH1__ mutations in the same amino acid strongly suggests that the mutations may play important roles in the path
BACKGROUND. Loss of heterozygosity (LOH) on chromosome arm 18q is common in sporadic prostate cancer and may be involved in cancer development through inactivation of tumor-suppressor genes (TSG). Recent identification, at 18q21.1, of MADR2/Smad2, a key component in transforming growth factor β€ (TGF
BACKGROUND. p53 is the most highly mutated tumor suppressor gene in human cancers. Recently, p73, a first homologue of p53, was identified and considered to be an imprinted tumor suppressor gene. Thus, we analyzed the possible role of p73 in human prostate cancers. METHODS. We investigated the expre